NCI (NCI) Stock Price & Analysis
NCI (NCI) rose 0.09% to USD 11.72 as of July 25, 2026 at 13:04 UTC, according to Nexqual real-time market data.
NCI last closed at USD 11.71; the session ranged USD 11.44–11.9 on volume of 254,510 shares. Market capitalization is $27.71M, with a 52-week range of USD 2.56–110.48 (NCM). Source: Nexqual, July 25, 2026 at 13:04 UTC.
Key Statistics (as of July 25, 2026 at 13:04 UTC)
| Price | USD 11.72 |
|---|---|
| Change | ▲ 0.09% (up) |
| Previous Close | USD 11.71 |
| Open | USD 11.74 |
| Day Range | USD 11.44 – 11.9 |
| 52-Week Range | USD 2.56 – 110.48 |
| Volume | 254,510 shares |
| Market Cap | $27.71M |
| Exchange | NCM |
Technical Analysis (NCI)
Nexqual's technical model rates NCI "NEUTRAL" based on 3 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 13:04 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 56.16 (neutral) |
| vs SMA50 | Above (USD 10.77) |
| MACD | 0.22 (positive) |
Analyst Ratings (NCI)
Wall Street analysts rate NCI "None", per Nexqual as of July 25, 2026 at 13:04 UTC.
| Consensus Rating | None |
|---|
Earnings (NCI)
Source: Nexqual, July 25, 2026 at 13:04 UTC.
Financials & Fundamentals (NCI)
| Total Revenue | $137.25M |
|---|---|
| Revenue Growth (YoY) | -50.80% |
| Gross Margin | +36.93% |
| Operating Margin | -0.59% |
| Profit Margin | +0.24% |
| ROE | +0.58% |
| Debt / Equity | 82.05 |
| Current Ratio | 2.61 |
| Total Cash | $2.33M |
| Total Debt | $46.44M |
| Free Cash Flow | $15.72M |
Source: Nexqual, July 25, 2026 at 13:04 UTC.
Financial Health Score (NCI)
Nexqual rates NCI's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 13:04 UTC.
| Growth | Critical — Revenue -51% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Gross margin 37%, operating -1% |
| Balance Sheet | Mixed — $2M cash vs $46M debt |
| Cash Flow | Solid — FCF $16M, 11% margin |
| Efficiency | Weak — ROE 1%, ROA 0.9% |
Ownership (NCI)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.08% |
| Shares Outstanding | 2.29M |
| Float | 490,161 |
| Short % of Float | +0.99% |
Source: Nexqual, July 25, 2026 at 13:04 UTC.
Leadership (NCI)
NCI is led by Yuk Yin Siu (age 62), Chairlady & CEO, per Nexqual as of July 25, 2026 at 13:04 UTC.
| Chairlady & CEO | Yuk Yin Siu (age 62) |
|---|---|
| Managing Director of Neo-Concept UK | Harriet Lewis (age 73) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FCN | FTI Consulting, Inc. | USD 159.79 | ▲ 2.1% |
| HURN | Huron Consulting Group Inc. | USD 112.3 | ▲ 0.68% |
| ELAB | PMGC Holdings Inc. | USD 0.9 | ▼ 11.76% |
| CRAI | CRA International,Inc. | USD 169.77 | ▲ 0.75% |
| PKE | Park Aerospace Corp. | USD 34.24 | ▲ 2.24% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 13:04 UTC. This page is informational and not investment advice.